Invention Application
- Patent Title: Anti-Viral Compounds
- Patent Title (中): 抗病毒化合物
-
Application No.: US15254342Application Date: 2016-09-01
-
Publication No.: US20170057981A1Publication Date: 2017-03-02
- Inventor: Hui-Ju J. Chen , David A. DeGoey , John Hartung , Nathan Ide , Vikram Kalthod , Allan C. Krueger , Yi-Yin Ku , Tongmei Li , John T. Randolph , Rolf Wagner , Jaclyn Chau , Geoff T. Halvorsen , Christopher C. Marvin , Eric Voight
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07F9/08
- IPC: C07F9/08
Abstract:
The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Public/Granted literature
- US09676797B2 Anti-viral compounds Public/Granted day:2017-06-13
Information query
